| Literature DB >> 27160230 |
Peter R Carroll1, J Kellogg Parsons2, Gerald Andriole3, Robert R Bahnson4, Erik P Castle5, William J Catalona6, Douglas M Dahl7, John W Davis8, Jonathan I Epstein9, Ruth B Etzioni10, Thomas Farrington11, George P Hemstreet12, Mark H Kawachi13, Simon Kim14, Paul H Lange15, Kevin R Loughlin16, William Lowrance17, Paul Maroni18, James Mohler19, Todd M Morgan20, Kelvin A Moses21, Robert B Nadler6, Michael Poch22, Chuck Scales23, Terrence M Shaneyfelt24, Marc C Smaldone25, Geoffrey Sonn26, Preston Sprenkle27, Andrew J Vickers28, Robert Wake29, Dorothy A Shead30, Deborah A Freedman-Cass30.
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.Entities:
Mesh：
Year: 2016 PMID： 27160230 DOI： 10.6004/jnccn.2016.0060
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908